Cover Image
Market Research Report
Product code 
1001816

HIV Drugs Global Market Report 2021: COVID 19 Implications And Growth to 2030

Published: Pre-Order | The Business Research Company | 175 Pages | Delivery time: 2-10 business days

Price

Back to Top
HIV Drugs Global Market Report 2021: COVID 19 Implications And Growth to 2030
Published: Pre-Order
The Business Research Company
Content info: 175 Pages
Delivery time: 2-10 business days
  • ALL
  • Description
  • Table of Contents
Description

“HIV Drugs Global Market Report 2021: COVID 19 Implications And Growth to 2030” from The Business Research Company covers this critical market and the impact on it from the Covid 19 virus. It provides strategists, marketers and senior management with the critical information they need to assess the increasing demand for HIV Drugs which play a critical role in the treatment of patients with Covid 19.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 20+ geographies.
  • Understand how the market is experiencing rapid growth due to the coronavirus and how it is likely to stabilize as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Where is the largest and fastest growing market for the hiv drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The HIV Drugs market global report from the Business Research Company ” answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider hiv drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the influence of the Covid 19 virus and forecasting its growth.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of Covid 19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The hiv drugs market section of the report gives context. It compares the hiv drugs market with other segments of the hiv drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, hiv drugs indicators comparison.

Scope

Markets Covered: 1) By Type: Nucleoside Reverse Transcriptase Inhibitors (NRT's); Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT's); Protease Inhibitors; Integrate Inhibitors; Fusion Inhibitors; Chemokine Receptor Inhibitors; Others

2) By Application: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies; Others

3) By Administration: Oral; Parenteral

Companies Mentioned: ViiV Healthcare; Gilead Sciences; Merck & Co., Inc.; Bristol-Myers Squibb Company; Janssen (Johnson&Johnson)

Countries: Brazil; China; France; Germany; India; Indonesia; Japan; South Korea; Russia; UK; USA; Australia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, per capita expenditure.

Data Segmentations:: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

Table of Contents

1. Executive Summary

2. HIV Drugs Market Characteristics

3. HIV Drugs Market Trends And Strategies

4. Impact Of COVID-19 On HIV Drugs

5. HIV Drugs Market Size And Growth

  • 5.1. Global HIV Drugs Historic Market, 2015-2020, $ Billion
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints On The Market
  • 5.2. Global HIV Drugs Forecast Market, 2020-2025F, 2030F, $ Billion
    • 5.2.1. Drivers Of The Market
    • 5.2.2. Restraints On the Market

6. HIV Drugs Market Segmentation

  • 6.1. Global HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Nucleoside Reverse Transcriptase Inhibitors (NRT's)
  • Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT's)
  • Protease Inhibitors
  • Integrate Inhibitors
  • Fusion Inhibitors
  • Chemokine Receptor Inhibitors
  • Others
  • 6.2. Global HIV Drugs Market, Segmentation By Application, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others
  • 6.3. Global HIV Drugs Market, Segmentation By Administration, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Oral
  • Parenteral

7. HIV Drugs Market Regional And Country Analysis

  • 7.1. Global HIV Drugs Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • 7.2. Global HIV Drugs Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

8. Asia-Pacific HIV Drugs Market

  • 8.1. Asia-Pacific HIV Drugs Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

9. China HIV Drugs Market

  • 9.1. China HIV Drugs Market Overview
  • 9.2. China HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

10. India HIV Drugs Market

  • 10.1. India HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

11. Japan HIV Drugs Market

  • 11.1. Japan HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

12. Australia HIV Drugs Market

  • 12.1. Australia HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

13. Indonesia HIV Drugs Market

  • 13.1. Indonesia HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

14. South Korea HIV Drugs Market

  • 14.1. South Korea HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

15. Western Europe HIV Drugs Market

  • 15.1. Western Europe HIV Drugs Market Overview
  • 15.2. Western Europe HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

16. UK HIV Drugs Market

  • 16.1. UK HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

17. Germany HIV Drugs Market

  • 17.1. Germany HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

18. France HIV Drugs Market

  • 18.3. France HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

19. Eastern Europe HIV Drugs Market

  • 19.1. Eastern Europe HIV Drugs Market Overview
  • 19.2. Eastern Europe HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

20. Russia HIV Drugs Market

  • 20.1. Russia HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

21. North America HIV Drugs Market

  • 21.1. North America HIV Drugs Market Overview
  • 21.2. North America HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

22. USA HIV Drugs Market

  • 22.1. USA HIV Drugs Market Overview
  • 22.2. USA HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

23. South America HIV Drugs Market

  • 23.1. South America HIV Drugs Market Overview
  • 23.2. South America HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

24. Brazil HIV Drugs Market

  • 24.1. Brazil HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

25. Middle East HIV Drugs Market

  • 25.1. Middle East HIV Drugs Market Overview
  • 25.2. Middle East HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

26. Africa HIV Drugs Market

  • 26.1. Africa HIV Drugs Market Overview
  • 26.2. Africa HIV Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

27. HIV Drugs Market Competitive Landscape And Company Profiles

  • 27.1. HIV Drugs Market Competitive Landscape
  • 27.2. HIV Drugs Market Company Profiles
    • 27.2.1. ViiV Healthcare
      • 27.2.1.1. Overview
      • 27.2.1.2. Products and Services
      • 27.2.1.3. Strategy
      • 27.2.1.4. Financial Performance
    • 27.2.2. Gilead Sciences
      • 27.2.2.1. Overview
      • 27.2.2.2. Products and Services
      • 27.2.2.3. Strategy
      • 27.2.2.4. Financial Performance
    • 27.2.3. Merck & Co., Inc.
      • 27.2.3.1. Overview
      • 27.2.3.2. Products and Services
      • 27.2.3.3. Strategy
      • 27.2.3.4. Financial Performance
    • 27.2.4. Bristol-Myers Squibb Company
      • 27.2.4.1. Overview
      • 27.2.4.2. Products and Services
      • 27.2.4.3. Strategy
      • 27.2.4.4. Financial Performance
    • 27.2.5. Janssen (Johnson&Johnson)
      • 27.2.5.1. Overview
      • 27.2.5.2. Products and Services
      • 27.2.5.3. Strategy
      • 27.2.5.4. Financial Performance

28. HIV Drugs Pipeline Analysis

29. Key Mergers And Acquisitions In The HIV Drugs Market

30. HIV Drugs Market Future Outlook and Potential Analysis

31. Appendix

  • 31.1. Abbreviations
  • 31.2. Currencies
  • 31.3. Research Inquiries
  • 31.4. The Business Research Company
  • 31.5. Copyright And Disclaimer